129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

NCT06104228 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension
Idiopathic Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)
Connective Tissue Diseases

Interventions

DRUG: 129Xe Hyperpolarized

Sponsor

Bastiaan Driehuys

Collaborators

[object Object]